These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 9133510
1. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, Krauss RM. Circulation; 1997 Apr 15; 95(8):2022-6. PubMed ID: 9133510 [Abstract] [Full Text] [Related]
2. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Alaupovic P, Kwong-Fu H, Azen SP. Ann Intern Med; 1996 Mar 15; 124(6):548-56. PubMed ID: 8597317 [Abstract] [Full Text] [Related]
7. [Comparison of lipid and lipoprotein(a) metabolism in blood serum and the thickness of common carotid artery (intima-media thickness complex-- IMT), in children from families at risk for cardiovascular disease and in families without risk]. Pac-Kozuchowska E, Zatorska-Karpuś M, Wieczorek P. Med Wieku Rozwoj; 2005 May 15; 9(2):171-8. PubMed ID: 16085958 [Abstract] [Full Text] [Related]
8. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, Björkegren J. J Am Coll Cardiol; 2005 Apr 05; 45(7):1013-7. PubMed ID: 15808756 [Abstract] [Full Text] [Related]
9. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. Arterioscler Thromb Vasc Biol; 1997 Apr 05; 17(4):715-22. PubMed ID: 9108785 [Abstract] [Full Text] [Related]
10. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H. Circulation; 1998 May 12; 97(18):1784-90. PubMed ID: 9603532 [Abstract] [Full Text] [Related]
11. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results. Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L. Online J Curr Clin Trials; 1992 Oct 23; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613 [Abstract] [Full Text] [Related]
20. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis. Björkegren J, Silveira A, Boquist S, Tang R, Karpe F, Bond MG, de Faire U, Hamsten A. Arterioscler Thromb Vasc Biol; 2002 Sep 01; 22(9):1470-4. PubMed ID: 12231568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]